Legend Biotech Corporation
USD29.39
+0.70 (+2.44%)
CEO
Ying Huang
IPO Date
2020-06-05
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$29.31
Prev. Close
$28.69
Day Low
$27.77
Day High
$29.41
52W Low
$16.24
52W High
$45.30
Market Cap
$5.44B
Volume
1.20M
| -33.6 |
| 31 Dec 2023 | FY | 49.4% | -181.8% | -41.4% | -28.0% | 0.26 | 6.92 | -20.4 |
| 31 Dec 2022 | FY | 44.1% | -381.5% | -60.0% | -33.5% | 0.38 | 3.69 | -17.8 |
| 31 Dec 2021 | FY | 100.0% | -586.4% | -52.7% | -36.1% | 0.16 | 4.14 | -16.3 |
| 31 Dec 2020 | FY | 100.0% | -355.2% | -44.6% | -36.9% | 0.01 | 5.14 | -12.5 |
| 31 Dec 2019 | FY | 100.0% | -164.4% | 82.7% | -35.3% | -0.05 | 1.62 | -48.1 |
| 31 Dec 2018 | FY | 100.0% | -5.7% | -32.2% | -0.6% | 0.50 | 2.05 | -1329.0 |
| 31 Dec 2017 | FY | 100.4% | 39.7% | 77.0% | 3.9% | 0.02 | 4.43 | 521.5 |
| -32.6 |
| 30 Sept 2025 | Q3 | 57.7% | -14.6% | -3.9% | -2.3% | 0.41 | 2.86 | -37.1 |
| 30 Jun 2025 | Q2 | 61.6% | -49.2% | -12.1% | -7.4% | 0.37 | 4.71 | -13.0 |
| 31 Mar 2025 | Q1 | 63.4% | -51.7% | -9.9% | -6.2% | 0.36 | 5.20 | -15.4 |
| 31 Dec 2024 | Q4 | 60.4% | 14.1% | 2.5% | 1.6% | 0.34 | 4.62 | 56.6 |
| 30 Sept 2024 | Q3 | 65.4% | -78.2% | -11.2% | -7.2% | 0.31 | 4.98 | -17.8 |
| 30 Jun 2024 | Q2 | 73.0% | -9.8% | -1.6% | -1.0% | 0.29 | 4.84 | -115.5 |
| 31 Mar 2024 | Q1 | 41.8% | -63.6% | -5.1% | -3.4% | 0.29 | 5.66 | -43.5 |
| 31 Dec 2023 | Q4 | 59.2% | -182.2% | -11.6% | -7.8% | 0.26 | 6.92 | -18.9 |